Somewhat different

Onyx Pharmaceuticals Inc. said a lung-cancer clinical trial of its flagship drug Nexavar was halted because it wouldn’t meet its goal of prolonging patient survival. An article about Onyx and the Abreast of the Market column yesterday incorrectly said the study was halted because of increased death in patients taking the drug. Link

  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Google
  • Fark
  • Furl
  • NewsVine
  • SphereIt
  • StumbleUpon
  • Technorati

Post a Comment

You must be logged in to post a comment.